Quince Therapeutics, Inc. (QNCX) Earnings Per Share (EPS)
Quince Therapeutics, Inc. (QNCX) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2019-12-31 | -$388.00 |
| 2020-12-31 | -$526.00 |
| 2021-12-31 | -$606.00 |
| 2022-12-31 | -$308.00 |
| 2023-12-31 | -$168.00 |
| 2024-12-31 | -$262.00 |
| 2025-12-31 | -$1.68 |
How QNCX compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| ENSG | The Ensign Group Inc. | $5.84 |
| ALGN | Align Technology Inc. | $5.65 |
| NBIX | Neurocrine Biosciences Inc. | $4.67 |
| CVS | CVS Health Corporation | $1.39 |
| AMN | AMN Healthcare Services Inc | -$2.48 |
These are five companies in the same sector as QNCX with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Quince Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("QNCX")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | QNCX | $34.04 | +0.00% | 0.03M |
| 3 | ||||
| 4 | ||||
| 5 |